Nanoparticles Targeted With NGR Motif Deliver c-myc siRNA and Doxorubicin for Anticancer Therapy

This publication has 24 references indexed in Scilit:

• Novel Cationic Lipid That Delivers siRNA and Enhances Therapeutic Effect in Lung Cancer Cells
  Molecular Pharmaceutics, 2009
• Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
  Pharmacological Reviews, 2004
• Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
  2003
• Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
  2003
• Identification of Binding Mechanisms in Single Molecule–DNA Complexes
  Biophysical Journal, 2003
• c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression
  Genes & Development, 2002
• Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
  2000
• Anti-cancer activity of targeted pro-apoptotic peptides
  Nature Medicine, 1999
• Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
  Science, 1998
• Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity
  Anti-Cancer Drugs, 1993